Natural adjuvants: endogenous activators of dendritic cells - PubMed (original) (raw)
. 1999 Nov;5(11):1249-55.
doi: 10.1038/15200.
Affiliations
- PMID: 10545990
- DOI: 10.1038/15200
Natural adjuvants: endogenous activators of dendritic cells
S Gallucci et al. Nat Med. 1999 Nov.
Abstract
Dendritic cells, the most potent antigen-presenting cells, need to be activated before they can function to initiate an immune response. We report here that, in the absence of any foreign substances, dendritic cells can be activated by endogenous signals received from cells that are stressed, virally infected or killed necrotically, but not by healthy cells or those dying apoptotically. Injected in vivo with an antigen, the endogenous activating substances can function as natural adjuvants to stimulate a primary immune response, and they may represent the natural initiators of transplant rejection, spontaneous tumor rejection, and some forms of autoimmunity.
Similar articles
- Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cells.
Paczesny S, Beranger S, Salzmann JL, Klatzmann D, Colombo BM. Paczesny S, et al. Cancer Res. 2001 Mar 15;61(6):2386-9. Cancer Res. 2001. PMID: 11289101 - Molecular identification of a danger signal that alerts the immune system to dying cells.
Shi Y, Evans JE, Rock KL. Shi Y, et al. Nature. 2003 Oct 2;425(6957):516-21. doi: 10.1038/nature01991. Epub 2003 Sep 7. Nature. 2003. PMID: 14520412 - Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H. Tanaka F, et al. Cancer Res. 2000 Sep 1;60(17):4838-44. Cancer Res. 2000. PMID: 10987295 - Environmental adjuvants, apoptosis and the censorship over autoimmunity.
Rovere-Querini P, Manfredi AA, Sabbadini MG. Rovere-Querini P, et al. Autoimmun Rev. 2005 Nov;4(8):555-60. doi: 10.1016/j.autrev.2005.04.013. Autoimmun Rev. 2005. PMID: 16214095 Review. - Natural killer or dendritic: what's in a name?
Spits H, Lanier LL. Spits H, et al. Immunity. 2007 Jan;26(1):11-6. doi: 10.1016/j.immuni.2007.01.004. Immunity. 2007. PMID: 17241957 Review.
Cited by
- Striking a balance: new perspectives on homeostatic dendritic cell maturation.
Bosteels V, Janssens S. Bosteels V, et al. Nat Rev Immunol. 2024 Sep 17. doi: 10.1038/s41577-024-01079-5. Online ahead of print. Nat Rev Immunol. 2024. PMID: 39289483 Review. - Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives.
Ren D, Xiong S, Ren Y, Yang X, Zhao X, Jin J, Xu M, Liang T, Guo L, Weng L. Ren D, et al. Comput Struct Biotechnol J. 2024 Apr 21;23:1833-1843. doi: 10.1016/j.csbj.2024.04.054. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 38707540 Free PMC article. Review. - Modern cancer therapy: cryoablation meets immune checkpoint blockade.
Liu Q, Zhang C, Chen X, Han Z. Liu Q, et al. Front Oncol. 2024 Feb 7;14:1323070. doi: 10.3389/fonc.2024.1323070. eCollection 2024. Front Oncol. 2024. PMID: 38384806 Free PMC article. Review. - Atopic dermatitis-associated genetic variants regulate LOC100294145 expression implicating interleukin-27 production and type 1 interferon signaling.
Teo WY, Lim YYE, Sio YY, Say YH, Reginald K, Chew FT. Teo WY, et al. World Allergy Organ J. 2024 Jan 12;17(2):100869. doi: 10.1016/j.waojou.2023.100869. eCollection 2024 Feb. World Allergy Organ J. 2024. PMID: 38298829 Free PMC article. - Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma.
Low JT, Brown MC, Reitman ZJ, Bernstock JD, Markert JM, Friedman GK, Waitkus MS, Bowie ML, Ashley DM. Low JT, et al. J Clin Invest. 2024 Jan 16;134(2):e163452. doi: 10.1172/JCI163452. J Clin Invest. 2024. PMID: 38226619 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources